BORYUNG PHARMBB

BORYUNG PHARM

8,740KRWD
+10+0.11%
At close at 07:44 GMT
KRW
No trades
See on Supercharts
Market capitalization
‪726.39 B‬KRW
‪69.63 B‬KRW
‪1.02 T‬KRW
‪27.11 M‬
Beta (1Y)
0.72

About BORYUNG PHARM


CEO
Jeong-Gyun Kim
Headquarters
Seoul
Founded
1963
ISIN
KR7003850005
FIGI
BBG000BGY7K6
Boryung Corp. engages in the manufacture, sales, and distribution of products related to pharmaceuticals and biotechnology. It offers products for hypertension and dyslipidemia, Oncology, specialty care, diabetes, renal, Central Nervous System (CNS), and over-the-counter (OTC). The company was founded on November 11, 1963 and is headquartered in Seoul, South Korea.
Performance
‪0.1%‬
‪2.6%‬
‪5.1%‬
‪7.6%‬
‪10.1%‬
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪0.00‬
‪‪70.00 B‬‬
‪‪140.00 B‬‬
‪‪210.00 B‬‬
‪‪280.00 B‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−90.00 B‬‬
‪0.00‬
‪‪90.00 B‬‬
‪‪180.00 B‬‬
‪‪270.00 B‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪70.00 B‬‬
‪‪140.00 B‬‬
‪‪210.00 B‬‬
‪‪280.00 B‬‬
Debt level and coverage
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪0.00‬
‪‪60.00 B‬‬
‪‪120.00 B‬‬
‪‪180.00 B‬‬
‪‪240.00 B‬‬
Debt
Free cash flow
Cash & equivalents
Earnings
Next:Feb 9, 2026
2021
2022
2023
2024
2025
‪0.00‬
‪300.00‬
‪600.00‬
‪900.00‬
‪‪1.20 K‬‬
Actual
Estimate

No news here

Looks like there's nothing to report right now

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 003850 is 8,740 KRW — it has increased by 0.11% in the past 24 hours. Watch BORYUNG PHARM stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange BORYUNG PHARM stocks are traded under the ticker 003850.
003850 stock has risen by 1.87% compared to the previous week, the month change is a 1.87% rise, over the last year BORYUNG PHARM has showed a −15.56% decrease.
003850 reached its all-time high on Jan 12, 2021 with the price of 24,600 KRW, and its all-time low was 370 KRW and was reached on Jun 24, 2004. View more price dynamics on 003850 chart.
See other stocks reaching their highest and lowest prices.
003850 stock is 2.77% volatile and has beta coefficient of 0.72. Track BORYUNG PHARM stock price on the chart and check out the list of the most volatile stocks — is BORYUNG PHARM there?
Today BORYUNG PHARM has the market capitalization of ‪733.00 B‬, it has increased by 3.56% over the last week.
Yes, you can track BORYUNG PHARM financials in yearly and quarterly reports right on TradingView.
BORYUNG PHARM revenue for the last quarter amounts to ‪240.20 B‬ KRW, despite the estimated figure of ‪240.20 B‬ KRW. In the next quarter, revenue is expected to reach ‪256.70 B‬ KRW.
003850 net income for the last quarter is ‪349.33 M‬ KRW, while the quarter before that showed ‪13.23 B‬ KRW of net income which accounts for −97.36% change. Track more BORYUNG PHARM financial stats to get the full picture.
Yes, 003850 dividends are paid annually. The last dividend per share was 100.00 KRW. As of today, Dividend Yield (TTM)% is 1.15%. Tracking BORYUNG PHARM dividends might help you take more informed decisions.
BORYUNG PHARM dividend yield was 0.97% in 2024, and payout ratio reached 9.81%. The year before the numbers were 0.84% and 16.38% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BORYUNG PHARM EBITDA is ‪107.63 B‬ KRW, and current EBITDA margin is 11.14%. See more stats in BORYUNG PHARM financial statements.
Like other stocks, 003850 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BORYUNG PHARM stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BORYUNG PHARM technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BORYUNG PHARM stock shows the sell signal. See more of BORYUNG PHARM technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.